Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial - Archive ouverte HAL Access content directly
Journal Articles Journal of Hepatology Year : 2018

Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial

Richard Finn
Philippe Merle
  • Function : Author
Alessandro Granito
  • Function : Author
Yi-Hsiang Huang
  • Function : Author
György Bodoky
Osamu Yokosuka
  • Function : Author
Chiara Caparello
  • Function : Author
Roniel Cabrera
  • Function : Author
Weijing Sun
  • Function : Author
Marie-Aude Leberre
  • Function : Author
Annette Baumhauer
  • Function : Author
Gerold Meinhardt
  • Function : Author
Jordi Bruix
  • Function : Author
Not file

Dates and versions

hal-02471037 , version 1 (07-02-2020)

Identifiers

Cite

Richard Finn, Philippe Merle, Alessandro Granito, Yi-Hsiang Huang, György Bodoky, et al.. Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial. Journal of Hepatology, 2018, 69 (2), pp.353-358. ⟨10.1016/j.jhep.2018.04.010⟩. ⟨hal-02471037⟩
39 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More